These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 570558)

  • 1. DI patient refractory to vasopressin and dDAVP: absence of antibodies to AVP and dDAVP and inactivating factor in blood serum.
    Slaninová J; Skopková J; Barth T; Lichardus B; Földes O
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):84-6. PubMed ID: 570558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypersensitivity against vasopressin and the synthetic vasopressin-analog DDAVP].
    Flachsbarth F; Wilhelms E
    MMW Munch Med Wochenschr; 1982 May; 124(19):485-6. PubMed ID: 6810116
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
    Laczi F; Mezei G; Julesz J; Lázló FA
    Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDAVP treatment of diabetes insipidus during pregnancy and the post-partum period.
    Burrow GN; Wassenaar W; Robertson GL; Sehl H
    Acta Endocrinol (Copenh); 1981 May; 97(1):23-5. PubMed ID: 7223315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of DDAVP in cranial diabetes insipidus as compared to other antidiuretic drugs.
    Coculescu M; Antipa C; Cucu C
    Endocrinologie; 1977; 15(4):275-81. PubMed ID: 563614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-year experience with DDAVP in treatment of diabetes insipidus.
    Marek J; Loutocký A; Pacovský V; Zaoral M
    Endokrinologie; 1978 May; 72(2):188-94. PubMed ID: 738214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regression of a massive hydronephrosis in familial central diabetes insipidus treated with Adiuretin].
    Kruse K
    Monatsschr Kinderheilkd; 1984 Aug; 132(8):612-4. PubMed ID: 6482884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pseudoresistance to DDAVP in diabetes insipidus].
    Radó J; Pató E; Czigner J; Fáber K
    Orv Hetil; 1985 Aug; 126(33):2043-6. PubMed ID: 4034192
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical use of DDAVP in a case of familial hypothalamo-pituitary diabetes insipidus].
    Filipponi P; Nicoletti I; Nunzi E; Benedetti Massi M; Santeusanio F
    Minerva Med; 1979 Jan; 70(4):347-56. PubMed ID: 431863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetes insipidus--with special reference to DDAVP therapy].
    Shimizu K
    Nihon Rinsho; 1979; 37(4):849-55. PubMed ID: 449070
    [No Abstract]   [Full Text] [Related]  

  • 11. [DDAVP in the treatment of acute neurosurgical diabetes insipidus].
    Zancaner F; Griner A; Galante E
    Minerva Med; 1984 Apr; 75(18):1063-7. PubMed ID: 6728257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Schwartz-Bartter syndrome following long-term DDAVP therapy in a patient with diabetes insipidus].
    Radó J; Pató E
    Orv Hetil; 1983 May; 124(22):1323-6. PubMed ID: 6877810
    [No Abstract]   [Full Text] [Related]  

  • 13. Recurrent diabetes insipidus associated with pregnancy: pathophysiology and therapy.
    Hughes JM; Barron WM; Vance ML
    Obstet Gynecol; 1989 Mar; 73(3 Pt 2):462-4. PubMed ID: 2915875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of central diabetes insipidus--mechanism of prolonged antidiuresis.
    Seif SM; Zenser TV; Ciarochi FF; Davis BB; Robinson AG
    J Clin Endocrinol Metab; 1978 Mar; 46(3):381-8. PubMed ID: 221517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin.
    Hammer M; Vilhardt H
    J Pharmacol Exp Ther; 1985 Sep; 234(3):754-60. PubMed ID: 4032289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of diabetes insipidus with synthetic vasopressin derivatives (effect of 1-deamino-8-D-arginine vasopressin and 1-deamino-valine-8-D-arginine vasopressin)].
    Czakó L; László F; Manning M
    Orv Hetil; 1980 Mar; 121(13):773-8. PubMed ID: 7383655
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of DDAVP (1-desamino-8-D-arginine vasopressin) in children with central diabetes insipidus (author's transl)].
    Tomita M; Nakagawa S; Saito N; Sakurada N; Nonoda A
    Horumon To Rinsho; 1979 Jun; 27(6):681-5. PubMed ID: 466837
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment and effects of desmopressin (DDAVP) in patients with central diabetes insipidus (author's transl)].
    Matsui K; Kimura T; Ota K; Iitake K; Yoshinaga K
    Horumon To Rinsho; 1979 Aug; 27(8):891-5. PubMed ID: 487624
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of vasopressin analogue DDAVP in patients with postoperative diabetes insipidus (author's transl)].
    Kubota T; Kashiwara K; Ito H; Tani K; Yamamoto S
    No To Shinkei; 1981 Jun; 33(3):617-23. PubMed ID: 7259900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of diabetes insipidus with a synthetic analog of vasopressin during pregnancy.
    Sack J; Friedman E; Katznelson D; Frenkel Y
    Isr J Med Sci; 1980 May; 16(5):406-7. PubMed ID: 7399872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.